Silencing MALAT1 represses pathological progression, inflammation, and vascular smooth muscle cell phenotype switching by regulating the SEMA3C-mediated Smad pathway in intracranial aneurysms
Silencing MALAT1 represses pathological progression, inflammation, and VSMC phenotype switching by regulating the SEMA3C-mediated Smad pathway in IA.
Authors
- Xinhua Tian
- Junjiang Tong
- Yue Gu (ORCID: https://orcid.org/0000-0002-8433-9604)
- Junlong Kang
- Feng Wei (ORCID: https://orcid.org/0000-0002-4797-449X)
- Wei Li (ORCID: https://orcid.org/0000-0001-9847-5140)
- Xue Gao (ORCID: https://orcid.org/0009-0006-4127-3808)
- Xiang Yao (ORCID: https://orcid.org/0000-0002-9232-3274)
- Luyue Chen
- Hongjin Chen
- Wei Feng
- E Chen
Institutions
- Fujian Medical University (CN)
- Fudan University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Huashan Hospital (CN)
- Third Hospital of Changsha (CN)
Publication Details
- Journal
- Frontiers in Cellular Neuroscience
- Published
- 2026-03-11
- DOI
- https://doi.org/10.3389/fncel.2026.1706518
- Primary Topic
- Axon Guidance and Neuronal Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Fujian Province